Ultrasonographic Comparison of Ovarian Stromal Blood Flow between Fertile Women with Normal Ovaries and Infertile Women with Polycystic Ovary Syndrome

Main Article Content

Reemal Shahid
Khadeeja Nasir
Muhammad Naveed Babur

Abstract

Background: Polycystic ovary syndrome (PCOS) is characterized by ovulatory dysfunction, hyperandrogenism, and altered ovarian morphology. Doppler ultrasonography may provide additional information regarding ovarian stromal vascular characteristics, although Doppler indices are not established as standalone diagnostic criteria for PCOS. Objective: To compare ovarian stromal blood-flow indices, ovarian morphology, and reproductive hormones between fertile women with normal ovaries and infertile women with PCOS and to examine relationships among vascular, structural, and hormonal markers. Methods: A cross-sectional comparative study included 120 women aged 20–35 years: 60 fertile controls and 60 infertile women with PCOS diagnosed using Rotterdam criteria. Transvaginal Doppler ultrasonography was performed on cycle days 2–4. Pulsatility index (PI), resistance index (RI), systolic-to-diastolic (S/D) ratio, vascularization index (VI), flow index (FI), vascularization-flow index (VFI), antral follicle count (AFC), and ovarian volume were assessed. Results: Participants with PCOS had substantially greater AFC (36.50±5.64 vs 15.43±4.34; mean difference 21.07, 95% CI 19.25–22.89) and ovarian volume (11.99±2.80 vs 6.11±1.30 mL; mean difference 5.88, 95% CI 5.09–6.67), together with higher PI, RI, VI, FI, and VFI; all p<0.001. FSH was lower, whereas LH and testosterone were higher in the PCOS group. VI correlated positively with AFC (r=.667), ovarian volume (r=.596), LH (r=.612), and testosterone (r=.591), whereas FSH was inversely related to VI (r=−.614) and FI (r=−.557); all p<0.001. Conclusion: PCOS was associated with marked structural, hormonal, and stromal vascular differences. Doppler indices may provide complementary physiological information but require standardized prospective validation before use for diagnosis or fertility prediction.

Article Details

Section

Articles

How to Cite

[1]
Shahid, R. et al. 2026. Ultrasonographic Comparison of Ovarian Stromal Blood Flow between Fertile Women with Normal Ovaries and Infertile Women with Polycystic Ovary Syndrome. Journal of Health, Wellness and Community Research. 4, 4 (Feb. 2026), 1–8. DOI:https://doi.org/10.61919/b5yb3b76.

References

1. Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023;108(10):2447–2469. doi:10.1210/clinem/dgad463.

2. Salari N, Nankali A, Ghanbari A, Jafarpour S, Ghasemi H, Dokaneheifard S, et al. Global prevalence of polycystic ovary syndrome in women worldwide: a comprehensive systematic review and meta-analysis. Arch Gynecol Obstet. 2024;310(3):1303–1314. doi:10.1007/s00404-024-07607-x.

3. Harada M. Pathophysiology of polycystic ovary syndrome revisited: current understanding and perspectives regarding future research. Reprod Med Biol. 2022;21(1). doi:10.1002/rmb2.12487.

4. Bozkurt M, Bozkurt DK, Kurban D, Takmaz T, Sevket O, Ozcan P. 2-D and 3-D ultrasonographic characteristics of the ovary in women with PCOS and multifollicular ovaries. J Obstet Gynaecol. 2021;41(6):920–926. doi:10.1080/01443615.2020.1803244.

5. Guzmán A, Hernández-Coronado CG, Gutiérrez CG, Rosales-Torres AM. The vascular endothelial growth factor (VEGF) system as a key regulator of ovarian follicle angiogenesis and growth. Mol Reprod Dev. 2023;90(4):201–217. doi:10.1002/mrd.23683.

6. Patil K, Joseph S, Shah J, Mukherjee S. An integrated in silico analysis highlighted angiogenesis regulating miRNA-mRNA network in PCOS pathophysiology. J Assist Reprod Genet. 2022;39(2):427–440. doi:10.1007/s10815-022-02396-1.

7. Pan HA, Wu MH, Cheng YC, Li CH, Chang FM. Quantification of Doppler signal in polycystic ovary syndrome using three-dimensional power Doppler ultrasonography: a possible new marker for diagnosis. Hum Reprod. 2002;17(1):201–206. doi:10.1093/humrep/17.1.201.

8. Schulten-Wijman MJNC, Struijk PC, Brezinka C, De Jong N, Steegers EAP. Evaluation of volume vascularization index and flow index: a phantom study. Ultrasound Obstet Gynecol. 2008;32(4):560–564. doi:10.1002/uog.6112.

9. Ng EHY, Chan CCW, Yeung WSB, Ho PC. Comparison of ovarian stromal blood flow between fertile women with normal ovaries and infertile women with polycystic ovary syndrome. Hum Reprod. 2005;20(7):1881–1886. doi:10.1093/humrep/deh853.

10. Wang WQ, Chu GH, Hou XX. A comparison of Doppler measures of ovarian blood flow between women with and without ovarian dysfunction and correlations of Doppler indices with ovarian dysfunction markers: a meta-analysis. Ann Transl Med. 2023;11(2):110. doi:10.21037/atm-22-5813.

11. Lam PM, Johnson IR, Raine-Fenning NJ. Three-dimensional ultrasound features of the polycystic ovary and the effect of different phenotypic expressions on these parameters. Hum Reprod. 2007;22(12):3116–3123. doi:10.1093/humrep/dem218.

12. Makled AK, El Sherbiny M, Elkabarity R. Assessment of ovarian stromal blood flow after metformin treatment in women with polycystic ovary syndrome. Arch Gynecol Obstet. 2014;289(4):883–891. doi:10.1007/s00404-013-3057-8.

13. Song L, Shi L, Liu W. Diagnosis values of three-dimensional power Doppler ultrasonography in polycystic ovary syndrome and its relationship with serum sex hormone levels. Steroids. 2023;194:109203. doi:10.1016/j.steroids.2023.109203.

14. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–47. doi:10.1093/humrep/deh098.

15. Bonovas S, Piovani D. Simpson’s paradox in clinical research: a cautionary tale. J Clin Med. 2023;12(4):1633. doi:10.3390/jcm12041633.